SDC1 and diffuse large B-cell lymphoma: Tumor biopsies of diffuse large B-cell lymphoma patients were examined for SDC1 expression and results tested positive in 30% of poor overall survival [113, 114], indicating aberrant SDC1 expression correlates with poor clinical outcome.